.START 

Bristol-Myers Squibb Co., New York, the newly merged drug and health-care-product company, reported record third-quarter earnings for both companies in the merger. 

Bristol-Myers Co. and Squibb Corp., Princeton, N.J., merged Oct. 4, but the new company reported third-period earnings for both companies.
For the fourth quarter, Bristol-Myers Squibb will report one set of earnings. 

Bristol-Myers said net income rose 15% to $266.2 million, or 93 cents a share, from $232.3 million, or 81 cents a share, a year earlier.
Sales gained 5% to $1.59 billion from $1.52 billion. 

Squibb Corp. said net rose 17% to $144.5 million, or $1.47 a share, from $123 million, or $1.25 a share.
Sales were $730.1 million, up 7% from $679.5 million. 

In New York Stock Exchange composite trading, Bristol-Myers Squibb rose $1.75 to $52.75. 

